Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

BFLY vs PRCT vs ISRG vs NVCR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BFLY
Butterfly Network, Inc.

Medical - Devices

HealthcareNYSE • US
Market Cap$1.11B
5Y Perf.-60.2%
PRCT
PROCEPT BioRobotics Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$1.45B
5Y Perf.-33.4%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+35.8%
NVCR
NovoCure Limited

Medical - Instruments & Supplies

HealthcareNASDAQ • JE
Market Cap$1.92B
5Y Perf.-84.6%

BFLY vs PRCT vs ISRG vs NVCR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BFLY logoBFLY
PRCT logoPRCT
ISRG logoISRG
NVCR logoNVCR
IndustryMedical - DevicesMedical - DevicesMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$1.11B$1.45B$161.07B$1.92B
Revenue (TTM)$103M$322M$10.58B$674M
Net Income (TTM)$-76M$-102M$2.98B$-173M
Gross Margin49.2%63.0%66.3%75.2%
Operating Margin-79.5%-33.9%30.5%-27.2%
Forward P/E43.3x
Total Debt$20M$52M$303M$290M
Cash & Equiv.$150M$287M$3.37B$103M

BFLY vs PRCT vs ISRG vs NVCRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BFLY
PRCT
ISRG
NVCR
StockSep 21May 26Return
Butterfly Network, … (BFLY)10039.8-60.2%
PROCEPT BioRobotics… (PRCT)10066.6-33.4%
Intuitive Surgical,… (ISRG)100135.8+35.8%
NovoCure Limited (NVCR)10015.4-84.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: BFLY vs PRCT vs ISRG vs NVCR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Butterfly Network, Inc. is the stronger pick specifically for recent price momentum and sentiment. PRCT also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
BFLY
Butterfly Network, Inc.
The Momentum Pick

BFLY is the #2 pick in this set and the best alternative if momentum is your priority.

  • +94.5% vs PRCT's -52.1%
Best for: momentum
PRCT
PROCEPT BioRobotics Corporation
The Growth Leader

PRCT is the clearest fit if your priority is growth.

  • 37.2% revenue growth vs NVCR's 8.3%
Best for: growth
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.02
  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.5% 10Y total return vs PRCT's -39.3%
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
Best for: income & stability and growth exposure
NVCR
NovoCure Limited
The Secondary Option

NVCR lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthPRCT logoPRCT37.2% revenue growth vs NVCR's 8.3%
Quality / MarginsISRG logoISRG28.2% margin vs BFLY's -73.6%
Stability / SafetyISRG logoISRGBeta 1.02 vs BFLY's 3.28, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)BFLY logoBFLY+94.5% vs PRCT's -52.1%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs BFLY's -25.6%, ROIC 15.0% vs -76.8%

BFLY vs PRCT vs ISRG vs NVCR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BFLYButterfly Network, Inc.
FY 2025
Product
65.0%$63M
Software And Other Services
35.0%$34M
PRCTPROCEPT BioRobotics Corporation

Segment breakdown not available.

ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
NVCRNovoCure Limited

Segment breakdown not available.

BFLY vs PRCT vs ISRG vs NVCR — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGNVCR

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 102.8x BFLY's $103M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to BFLY's -73.6%. On growth, BFLY holds the edge at +25.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBFLY logoBFLYButterfly Network…PRCT logoPRCTPROCEPT BioRoboti…ISRG logoISRGIntuitive Surgica…NVCR logoNVCRNovoCure Limited
RevenueTrailing 12 months$103M$322M$10.6B$674M
EBITDAEarnings before interest/tax-$76M-$102M$3.8B-$165M
Net IncomeAfter-tax profit-$76M-$102M$3.0B-$173M
Free Cash FlowCash after capex-$19M-$81M$2.8B-$48M
Gross MarginGross profit ÷ Revenue+49.2%+63.0%+66.3%+75.2%
Operating MarginEBIT ÷ Revenue-79.5%-33.9%+30.5%-27.2%
Net MarginNet income ÷ Revenue-73.6%-31.8%+28.2%-25.7%
FCF MarginFCF ÷ Revenue-18.3%-25.0%+26.8%-7.1%
Rev. Growth (YoY)Latest quarter vs prior year+25.0%+20.2%+23.0%+12.3%
EPS Growth (YoY)Latest quarter vs prior year+16.0%-24.4%+18.8%-100.0%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRCT leads this category, winning 2 of 3 comparable metrics.
MetricBFLY logoBFLYButterfly Network…PRCT logoPRCTPROCEPT BioRoboti…ISRG logoISRGIntuitive Surgica…NVCR logoNVCRNovoCure Limited
Market CapShares × price$1.1B$1.4B$161.1B$1.9B
Enterprise ValueMkt cap + debt − cash$979M$1.2B$158.0B$2.1B
Trailing P/EPrice ÷ TTM EPS-13.68x-14.79x57.62x-13.80x
Forward P/EPrice ÷ next-FY EPS est.43.35x
PEG RatioP/E ÷ EPS growth rate2.65x
EV / EBITDAEnterprise value multiple43.62x
Price / SalesMarket cap ÷ Revenue11.37x4.70x16.00x2.92x
Price / BookPrice ÷ Book value/share5.35x3.86x9.17x5.51x
Price / FCFMarket cap ÷ FCF64.67x
PRCT leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-51 for NVCR. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVCR's 0.85x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs BFLY's 3/9, reflecting solid financial health.

MetricBFLY logoBFLYButterfly Network…PRCT logoPRCTPROCEPT BioRoboti…ISRG logoISRGIntuitive Surgica…NVCR logoNVCRNovoCure Limited
ROE (TTM)Return on equity-36.8%-27.7%+16.9%-50.8%
ROA (TTM)Return on assets-25.6%-20.3%+14.8%-16.5%
ROICReturn on invested capital-76.8%-55.7%+15.0%-16.4%
ROCEReturn on capital employed-39.3%-22.5%+16.5%-28.9%
Piotroski ScoreFundamental quality 0–93565
Debt / EquityFinancial leverage0.10x0.14x0.02x0.85x
Net DebtTotal debt minus cash-$130M-$235M-$3.1B$187M
Cash & Equiv.Liquid assets$150M$287M$3.4B$103M
Total DebtShort + long-term debt$20M$52M$303M$290M
Interest CoverageEBIT ÷ Interest expense-71.59x-30.92x-96.80x
ISRG leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BFLY leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $875 for NVCR. Over the past 12 months, BFLY leads with a +94.5% total return vs PRCT's -52.1%. The 3-year compound annual growth rate (CAGR) favors BFLY at 26.2% vs NVCR's -37.6% — a key indicator of consistent wealth creation.

MetricBFLY logoBFLYButterfly Network…PRCT logoPRCTPROCEPT BioRoboti…ISRG logoISRGIntuitive Surgica…NVCR logoNVCRNovoCure Limited
YTD ReturnYear-to-date+13.1%-17.3%-19.3%+28.3%
1-Year ReturnPast 12 months+94.5%-52.1%-15.4%+1.1%
3-Year ReturnCumulative with dividends+100.9%-7.8%+49.6%-75.7%
5-Year ReturnCumulative with dividends-65.1%-39.3%+58.7%-91.3%
10-Year ReturnCumulative with dividends-57.2%-39.3%+554.2%+30.3%
CAGR (3Y)Annualised 3-year return+26.2%-2.7%+14.4%-37.6%
BFLY leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ISRG and NVCR each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than BFLY's 3.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVCR currently trades 83.9% from its 52-week high vs PRCT's 38.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBFLY logoBFLYButterfly Network…PRCT logoPRCTPROCEPT BioRoboti…ISRG logoISRGIntuitive Surgica…NVCR logoNVCRNovoCure Limited
Beta (5Y)Sensitivity to S&P 5003.23x1.14x1.00x2.15x
52-Week HighHighest price in past year$5.72$66.85$603.88$20.06
52-Week LowLowest price in past year$1.32$19.35$427.84$9.82
% of 52W HighCurrent price vs 52-week peak+74.1%+38.1%+75.1%+83.9%
RSI (14)Momentum oscillator 0–10046.250.942.469.8
Avg Volume (50D)Average daily shares traded6.4M1.7M1.8M1.5M
Evenly matched — ISRG and NVCR each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: BFLY as "Buy", PRCT as "Buy", ISRG as "Buy", NVCR as "Buy". Consensus price targets imply 99.0% upside for NVCR (target: $34) vs 27.8% for BFLY (target: $5).

MetricBFLY logoBFLYButterfly Network…PRCT logoPRCTPROCEPT BioRoboti…ISRG logoISRGIntuitive Surgica…NVCR logoNVCRNovoCure Limited
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$5.42$42.40$622.60$33.50
# AnalystsCovering analysts7155515
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+1.4%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRCT leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 2 of 6 categories
Loading custom metrics...

BFLY vs PRCT vs ISRG vs NVCR: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is BFLY or PRCT or ISRG or NVCR a better buy right now?

For growth investors, PROCEPT BioRobotics Corporation (PRCT) is the stronger pick with 37.

2% revenue growth year-over-year, versus 8. 3% for NovoCure Limited (NVCR). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 6x trailing P/E (43. 3x forward), making it the more compelling value choice. Analysts rate Butterfly Network, Inc. (BFLY) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — BFLY or PRCT or ISRG or NVCR?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -91. 3% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus BFLY's -58. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — BFLY or PRCT or ISRG or NVCR?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 00β versus Butterfly Network, Inc. 's 3. 23β — meaning BFLY is approximately 224% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 85% for NovoCure Limited — giving it more financial flexibility in a downturn.

04

Which is growing faster — BFLY or PRCT or ISRG or NVCR?

By revenue growth (latest reported year), PROCEPT BioRobotics Corporation (PRCT) is pulling ahead at 37.

2% versus 8. 3% for NovoCure Limited (NVCR). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to 1. 7% for PROCEPT BioRobotics Corporation. Over a 3-year CAGR, PRCT leads at 60. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — BFLY or PRCT or ISRG or NVCR?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -79. 0% for Butterfly Network, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -88. 5% for BFLY. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is BFLY or PRCT or ISRG or NVCR more undervalued right now?

Analyst consensus price targets imply the most upside for NVCR: 99.

0% to $33. 50.

07

Which pays a better dividend — BFLY or PRCT or ISRG or NVCR?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is BFLY or PRCT or ISRG or NVCR better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +549. 2% 10Y return). Butterfly Network, Inc. (BFLY) carries a higher beta of 3. 23 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +549. 2%, BFLY: -58. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between BFLY and PRCT and ISRG and NVCR?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BFLY is a small-cap high-growth stock; PRCT is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock; NVCR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BFLY

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Gross Margin > 29%
Run This Screen
Stocks Like

PRCT

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Gross Margin > 37%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

NVCR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 45%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BFLY and PRCT and ISRG and NVCR on the metrics below

Revenue Growth>
%
(BFLY: 25.0% · PRCT: 20.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.